Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
Generics seek brands, Big pharma seek generics!
July 1, 2009
Lupin Expands Branded Play | www.sunherald.com
Generic companies have the creative R&D to develop value-added products and compete head-to-head with branded companies Branded companies see generics as an easy way to add products for their sales teams
January 21, 2009
Teva and Lonza Announce Strategic Partnership to Become a Leading Global Provider of Biosimilars | www.pipelinereview.com
I think it shows two important things: 1) Teva admit that they are not in the best position to manufacture 2) That Teva remove a potential manufacturing competitor from the market
January 20, 2009
Aurobindo Pharma gets approval for Terbinafine Tablets | myiris.com
The market is in decline, ALL major generic companies already have the product.. the only way for Aurobindo to get market share is to undercut the competition. With little margin already, not a money spinner.
All brawn and not enough brains
October 8, 2008
Pharma's new favorite outsourcing spot: China | www.fiercepharma.com
Yes the trend will continue, but with limitations, for now. China IS most definitely already a source for pharmaceutical manufacturing, but has a long way to go before becoming an independent creator of pharmaceutical intellectual property. Once it can, then outsourcing will really take off.
Page : 11 to 4 of 4
FDA Publishes H1N1 Diagnostic Test Guidance
November 5, 2009
Synta Drug for Metastatic Melanoma Not Dead Yet (?)
November 3, 2009
Pharma Outsourcing: Where Will it End?
November 3, 2009
Delcath Phase III trial for metastatic melanoma completes enrollment
November 3, 2009
Healthy if You're Wealthy: Ghana offers Choices
November 2, 2009
www.reuters.com
www.businesswire.com
Synta Pharmaceuticals Announces Updated Elesclomol SYMMETRYSM Data Presented at Melanoma XIII
www.outsourcing-pharma.com
www.genomeweb.com
www.pharmabiz.com
Novartis to invest US$ 1 bn to build largest pharma R&D institute in China